At the ISCT 2018 Annual Meeting in Montreal, Mill Creek Life Sciences presented a poster titled: In vitro expansion of human primary endothelial cells for clinical use using EndoGo™ XF Medium supplemented with PLTGold® human platelet lysate.
News and Updates
Featured Article
Feb 07 2020
“Based on promising results in an early clinical trial, Mayo Clinic has formed a new joint venture with materials engineering firm W.L. Gore & Associates to spearhead a new therapy using stem cells to repair a painful tissue problem stemming from Crohn's disease.”
Feb 07 2020
“Based on promising results in an early clinical trial, Mayo Clinic has formed a new joint venture with materials engineering firm W.L. Gore & Associates to spearhead a new therapy using stem cells to repair a painful tissue problem stemming from Crohn's disease.”
Feb 07 2020
"Stem cells derived from a patient's own fat offer a step toward improving — not just stabilizing — motor and sensory function of people with spinal cord injuries, according to early research from Mayo Clinic."
- 1 of 6
- Next
Press Releases
Jun 28 2017
At the ISCT 2017 Annual Meeting in London, Mill Creek Life Sciences presented a poster titled: In Vitro Expansion of Mesenchymal Stem Cells Using Media Supplemented with Unfractionated, Heparin-Free Platelet Lysate.
Mar 09 2017
Biological Industries USA Signs Agreement with
Mill Creek Life Sciences to add PLTMax® Human Platelet Lysate
to its Growing Stem Cell Portfolio
Jul 27 2016
Not enough time to look around our website? Download our current info card to learn more about Mill Creek Life Sciences and PLTMax®!
- 1 of 2
- Next
Contact
Available from these distributors!
Research grade PLTMax® and PLTGold® are available from LAgen Laboratories in the 100mL bottle size.